Metformin, diet and physical activity influence on the overweight and obesity in childre
- Conditions
- The aim of our study is to establish the effectivenes and safety of metformin use in pediatric obese populationto assess the prevalence of insulin resistance, metabolic syndrome, polycystic ovary syndrome (PCOS), impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM) among overweight and obese children and adolescents in Lithuania, and to determine the effect of targeted interventions (lifestyle and metformin) in controlling obesity and associated diseases risk.MedDRA version: 14.1Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: PTClassification code 10033307Term: OverweightSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]
- Registration Number
- EUCTR2011-006352-36-LT
- Lead Sponsor
- ithuanian University of Health Sciences, Endocrinology Department
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 100
•Age 10-17 yrs;
•BMI > 85th percentile for age and gender (by IOTF);
•Living in Kaunas and its region;
•No obvious chronic diseases;
•Not on long-term steroid oral / IV treatment;
•Childbearing age ladies using contraception;
•Informed consent of the patient and parents (official caregivers);
Are the trial subjects under 18? yes
Number of subjects for this age range: 100
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
•Age less than 10 or above 17 yrs;
•Diagnosis of type 1 diabetes;
•Chronic illness that may affect physical activity, hormone and metabolic profile;
•Insulin treatment;
•Steroid treatment;
•Planning to move from Kaunas or its region in the period of 1 year;
•Childbearing age ladies non- using contraception, pregnancy planning;
•Protocol refused by the patient or his parents;
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method